BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 23935019)

  • 1. Characteristic phenotypes associated with congenital dyserythropoietic anemia (type II) manifest at different stages of erythropoiesis.
    Satchwell TJ; Pellegrin S; Bianchi P; Hawley BR; Gampel A; Mordue KE; Budnik A; Fermo E; Barcellini W; Stephens DJ; van den Akker E; Toye AM
    Haematologica; 2013 Nov; 98(11):1788-96. PubMed ID: 23935019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of a red blood cell phenotype in mice with hematopoietic deficiency of SEC23B.
    Khoriaty R; Vasievich MP; Jones M; Everett L; Chase J; Tao J; Siemieniak D; Zhang B; Maillard I; Ginsburg D
    Mol Cell Biol; 2014 Oct; 34(19):3721-34. PubMed ID: 25071156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II.
    Schwarz K; Iolascon A; Verissimo F; Trede NS; Horsley W; Chen W; Paw BH; Hopfner KP; Holzmann K; Russo R; Esposito MR; Spano D; De Falco L; Heinrich K; Joggerst B; Rojewski MT; Perrotta S; Denecke J; Pannicke U; Delaunay J; Pepperkok R; Heimpel H
    Nat Genet; 2009 Aug; 41(8):936-40. PubMed ID: 19561605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functions of the COPII gene paralogs SEC23A and SEC23B are interchangeable in vivo.
    Khoriaty R; Hesketh GG; Bernard A; Weyand AC; Mellacheruvu D; Zhu G; Hoenerhoff MJ; McGee B; Everett L; Adams EJ; Zhang B; Saunders TL; Nesvizhskii AI; Klionsky DJ; Shavit JA; Gingras AC; Ginsburg D
    Proc Natl Acad Sci U S A; 2018 Aug; 115(33):E7748-E7757. PubMed ID: 30065114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAP-011 Rescues the Disease Phenotype in a Cellular Model of Congenital Dyserythropoietic Anemia Type II by Inhibiting the SMAD2-3 Pathway.
    De Rosa G; Andolfo I; Marra R; Manna F; Rosato BE; Iolascon A; Russo R
    Int J Mol Sci; 2020 Aug; 21(15):. PubMed ID: 32759740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach.
    Iolascon A; Esposito MR; Russo R
    Haematologica; 2012 Dec; 97(12):1786-94. PubMed ID: 23065504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital dyserythropoietic anaemia type II (HEMPAS) and its molecular basis.
    Fukuda MN
    Baillieres Clin Haematol; 1993 Jun; 6(2):493-511. PubMed ID: 8043936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Cases and Mutations in
    Musri MM; Venturi V; Ferrer-Cortès X; Romero-Cortadellas L; Hernández G; Leoz P; Ricard Andrés MP; Morado M; Fernández Valle MDC; Beneitez Pastor D; Ortuño Cabrero A; Moreno Gamiz M; Senent Peris L; Perez-Valencia AI; Pérez-Montero S; Tornador C; Sánchez M
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SEC23A rescues SEC23B-deficient congenital dyserythropoietic anemia type II.
    King R; Lin Z; Balbin-Cuesta G; Myers G; Friedman A; Zhu G; McGee B; Saunders TL; Kurita R; Nakamura Y; Engel JD; Reddy P; Khoriaty R
    Sci Adv; 2021 Nov; 7(48):eabj5293. PubMed ID: 34818036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transduction with BBF2H7/CREB3L2 upregulates SEC23A protein in erythroblasts and partially corrects the hypo-glycosylation phenotype associated with CDAII.
    Pellegrin S; Haydn-Smith KL; Hampton-O'Neil LA; Hawley BR; Heesom KJ; Fermo E; Bianchi P; Toye AM
    Br J Haematol; 2019 Mar; 184(5):876-881. PubMed ID: 29536501
    [No Abstract]   [Full Text] [Related]  

  • 11. VPS4A Mutations in Humans Cause Syndromic Congenital Dyserythropoietic Anemia due to Cytokinesis and Trafficking Defects.
    Seu KG; Trump LR; Emberesh S; Lorsbach RB; Johnson C; Meznarich J; Underhill HR; Chou ST; Sakthivel H; Nassar NN; Seu KJ; Blanc L; Zhang W; Lutzko CM; Kalfa TA
    Am J Hum Genet; 2020 Dec; 107(6):1149-1156. PubMed ID: 33186543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B gene.
    Bianchi P; Fermo E; Vercellati C; Boschetti C; Barcellini W; Iurlo A; Marcello AP; Righetti PG; Zanella A
    Hum Mutat; 2009 Sep; 30(9):1292-8. PubMed ID: 19621418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Congenital dyserythropoietic anemia type II: molecular analysis and expression of the SEC23B gene.
    Punzo F; Bertoli-Avella AM; Scianguetta S; Della Ragione F; Casale M; Ronzoni L; Cappellini MD; Forni G; Oostra BA; Perrotta S
    Orphanet J Rare Dis; 2011 Dec; 6():89. PubMed ID: 22208203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital dyserythropoietic anemia, type II with SEC23B exon 12 c.1385 A → G mutation, and pseudo-Gaucher cells in two siblings.
    Sharma P; Das R; Bansal D; Trehan A
    Hematology; 2015 Mar; 20(2):104-7. PubMed ID: 24801240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital dyserythropoietic anemia.
    Kamiya T; Manabe A
    Int J Hematol; 2010 Oct; 92(3):432-8. PubMed ID: 20820969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypomorphic mutations of SEC23B gene account for mild phenotypes of congenital dyserythropoietic anemia type II.
    Russo R; Langella C; Esposito MR; Gambale A; Vitiello F; Vallefuoco F; Ek T; Yang E; Iolascon A
    Blood Cells Mol Dis; 2013 Jun; 51(1):17-21. PubMed ID: 23453696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Congenital dyserythropoietic anemia type II: a case report and literature review].
    Li Y; Zhao X; Zhou K; Li Y; Li JP; Ye L; Peng GX; Fan HH; Jing LP; Zhang L; Zhang FK
    Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):270-3. PubMed ID: 22781715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablation of
    Kumari R; Grzywa TM; Małecka-Giełdowska M; Tyszkowska K; Wrzesień R; Ciepiela O; Nowis D; Kaźmierczak P
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codanin-1 mutations in congenital dyserythropoietic anemia type 1 affect HP1{alpha} localization in erythroblasts.
    Renella R; Roberts NA; Brown JM; De Gobbi M; Bird LE; Hassanali T; Sharpe JA; Sloane-Stanley J; Ferguson DJ; Cordell J; Buckle VJ; Higgs DR; Wood WG
    Blood; 2011 Jun; 117(25):6928-38. PubMed ID: 21364188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital dyserythropoietic anemia type II in a newborn with a novel compound heterozygous mutation in the SEC23B: a case report and review of the literature.
    Zheng J; Gao L; Liu H; Xiao P; Lu J; Li J; Wu S; Cheng S; Bian X; Du Z; Kong L; Hu S; Fan J
    Int J Hematol; 2024 Feb; 119(2):210-214. PubMed ID: 38127226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.